112 related articles for article (PubMed ID: 28459994)
1. The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.
Kuijer A; Verloop J; Visser O; Sonke G; Jager A; van Gils CH; van Dalen T; Elias SG
Ann Oncol; 2017 Aug; 28(8):1970-1978. PubMed ID: 28459994
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.
Verschoor AM; Kuijer A; Verloop J; Van Gils CH; Sonke GS; Jager A; van Dalen T; Elias SG
Breast Cancer Res Treat; 2016 Sep; 159(2):357-65. PubMed ID: 27514397
[TBL] [Abstract][Full Text] [Related]
3. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
4. Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.
Schreuder K; Kuijer A; Rutgers EJT; Smorenburg CH; van Dalen T; Siesling S
Eur J Cancer; 2017 Oct; 84():270-277. PubMed ID: 28844015
[TBL] [Abstract][Full Text] [Related]
5. Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands.
Aarts MJ; Hamelinck VC; Bastiaannet E; Coebergh JW; Liefers GJ; Voogd AC; van der Sangen M; Louwman WJ
Br J Cancer; 2012 Jun; 107(1):12-7. PubMed ID: 22596236
[TBL] [Abstract][Full Text] [Related]
6. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
7. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Kumachev A; Trudeau ME; Chan KK
Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
[TBL] [Abstract][Full Text] [Related]
8. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
[TBL] [Abstract][Full Text] [Related]
9. Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.
Kuijer A; van Bommel AC; Drukker CA; van der Heiden-van der Loo M; Smorenburg CH; Westenend PJ; Linn SC; Rutgers EJ; Elias SG; van Dalen T
Genet Med; 2016 Jul; 18(7):720-6. PubMed ID: 26583684
[TBL] [Abstract][Full Text] [Related]
10. Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
van den Berg I; van de Weerd S; van Klaveren D; Coebergh van den Braak RRJ; van Krieken JHJM; Koopman M; Roodhart JML; Medema JP; IJzermans JNM
Eur J Surg Oncol; 2021 Aug; 47(8):2060-2068. PubMed ID: 33745794
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.
Keikes L; van Oijen MGH; Lemmens VEPP; Koopman M; Punt CJA
Clin Colorectal Cancer; 2018 Mar; 17(1):58-64. PubMed ID: 29157662
[TBL] [Abstract][Full Text] [Related]
12. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
14. Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II.
Stüber T; van Ewijk R; Diessner J; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S; Schwentner L
Breast Cancer; 2017 Mar; 24(2):281-287. PubMed ID: 27193566
[TBL] [Abstract][Full Text] [Related]
15. Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.
Schwentner L; Van Ewijk R; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S
Support Care Cancer; 2016 Jun; 24(6):2759-66. PubMed ID: 26816089
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands.
van Maaren MC; Rachet B; Sonke GS; Mauguen A; Rondeau V; Siesling S; Belot A
Cancer Epidemiol; 2022 Apr; 77():102118. PubMed ID: 35131686
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic status significantly contributes to the likelihood of immediate postmastectomy breast reconstruction in the Netherlands: A nationwide study.
Filipe MD; Siesling S; Vriens MR; van Diest PJ; Witkamp AJ; Mureau MAM
Eur J Surg Oncol; 2021 Feb; 47(2):245-250. PubMed ID: 32981793
[TBL] [Abstract][Full Text] [Related]
18. Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands.
de Munck L; Schaapveld M; Siesling S; Wesseling J; Voogd AC; Tjan-Heijnen VC; Otter R; Willemse PH
Breast Cancer Res Treat; 2011 Aug; 129(1):229-33. PubMed ID: 21431871
[TBL] [Abstract][Full Text] [Related]
19. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
Parise CA; Caggiano V
BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
[TBL] [Abstract][Full Text] [Related]
20. The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands.
Filipe MD; Siesling S; Vriens MR; van Diest P; Witkamp AJ
Breast Cancer Res Treat; 2021 Sep; 189(2):541-550. PubMed ID: 34176084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
